|
|
|
|
|
by kazinator
3171 days ago
|
|
Developing drugs is very expensive. It takes years of research, most of which fails. I.e. out of the various molecules being researched, only few actually make it through all the trials and approval and get to market. Due to the risk, investors are looking for high returns from successful drugs. |
|
Now imagine if we had a regulation that both forbade universities from issuing patents and limited the price of any drug that is initially based on public funded research.